September 2021 – Policy & Medicine

Teva Pharmaceuticals’ Motion to Dismiss Denied

Endo International Plc Reaches $50 Million Settlement with New York State and Counties

HHS OIG and DOJ Release Annual Report

CBO Simulates the Elijah E. Cummings Lower Drug Costs Now Act

OPDP Sends Third Untitled Letter of the Year to Eton Pharmaceuticals

FDA Reconsidering the Need for Mandatory Opioid Prescriber Education

Sutter Health Reaches $90 Million Settlement Over Alleged False Claims Act Violations

Fifth Circuit Court of Appeals Allows Government to Dismiss FCA Cases Against Eli Lilly and Bayer

Telemedicine Fraud Scheme Results in Civil and Criminal Enforcement Actions Against Practitioners

Alternative Drug Pricing Legislation Introduced by Moderate Democrats